Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
107.50    -1.50 (-1.38%)
Bid:
105.00
Ask:
107.00
Spread: 2.00 (1.905%)
Market Cap: £105.94m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Director/PDMR Shareholding

1 Apr 2020 15:22

RNS Number : 4576I
Eurocell plc
01 April 2020
Β 

1 April 2020

Eurocell PLC

(the "Company")

Β 

Director/PDMR Shareholding

Β 

Eurocell PLC announces that certain Directors and PDMRs of the Company have subscribed for, as part of the Company's placing announced on 1 April 2020, the following shares as set out below.

Β 

The notifications below, made in accordance with requirements of the EU Market Abuse Regulation, provide further details.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them

Β 

1 - Details of the person discharging managerial responsibilities / person closely associated

Name

1.

Bob Lawson

2.

Mark Kelly

3.

Michael Scott

4.

Frank Nelson

5.

Martyn Coffey

6.

Sucheta Govil

2 - Reason for the notification

Position

1.

Chairman

2.

Chief Executive Officer

3.

Chief Financial Officer

4.

Senior Non-Executive Director

5.

Non-Executive Director

6.

Non-Executive Director

Reason for the notification

Initial Notification

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Full name of the entity

Eurocell PLC

Legal Entity Identifier code

213800RH62IQ7S9OFQ55

4 - Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

Description of financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

ISIN: GB00BVV2KN49

Nature of the transaction

Purchase

Price(s) and volume(s)

Name

Price(s)

Volume(s)

1.

Bob Lawson

175p

14,285

2.

Mark Kelly

175p

14,285

3.

Michael Scott

175p

5,714

4.

Frank Nelson

175p

5,714

5.

Martyn Coffey

175p

5,714

6.

Sucheta Govil

175p

5,714

Aggregated information and volume price

N/A (single transaction)

Date of transaction

1 April 2020

Place of transaction

London Stock Exchange

Β 

Β 

Enquiries:

Β 

Eurocell plc

Β 

Mark Kelly, Chief Executive Officer

Β 

Michael Scott, Chief Financial Officer

Β 

Β 

Β 

via Teneo

Β 

Teneo

Β 

Ben Foster

Β 

Camilla Cunningham

Β 

Β 

Β 

Tel: +44 (0) 20 3603 5221

Β 

Tel: +44 (0) 20 3757 9235

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHUPURGCUPUGCG
Date   Source Headline
18th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20261:49 pmRNSResult of AGM
14th May 20267:00 amRNSTrading Update
1st May 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSLeadership Update - CFO Appointment
15th Apr 20267:00 amRNSPublication of 2025 Annual Report & Notice of AGM
23rd Mar 202610:15 amRNSDirector/PDMR Shareholding
19th Mar 202610:30 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2025
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
17th Feb 20267:00 amRNSTransaction in Own Shares - Buyback Complete
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20261:00 pmRNSDirectorate changes
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSDirector/PDMR Shareholding
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSYear End Trading Update
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:00 pmRNSPurchase of Shares via Employee Benefit Trust
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.